| Date | Title | Description |
| 23.03.2026 | The OpenClaw wave is bigger in China than elsewhere in the world: Qiming Venture Partners | Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET |
| 17.03.2026 | RoboForce Secures $52M to Propel Industrial AI Robotics | RoboForce secures $52 million in new funding. This propels the company's Physical AI robotics for industrial labor. The capital accelerates robot foundation model development, manufacturing scale, and commercial deployments. Total funding n... |
| 16.03.2026 | RoboForce: $52 Million Raised To Scale Physical AI Robo-Labor | RoboForce, a developer of Physical AI-powered robotics systems for industrial labor, announced it has raised $52 million in an oversubscribed funding round as it moves from research and development toward scaled commercial deployments. The ... |
| 16.03.2026 | RoboForce raises $52M to develop physical AI robots for industrial labor
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Robotics startup RoboForce Inc. announced today that it has raised $52 million in new funding to accelerate its next-generation robot foundation model, scale up general-purpose physical artificial intelligence robots and drive manufacturing... |
| 13.03.2026 | Alibaba leads RMB 500 million investment in BCI startup StairMed | StairMed, a brain-computer interface (BCI) developer, has secured RMB 500 million (USD 72.7 million) in a funding round led by Alibaba Group, with participation from SDIC Unity Capital. Existing investors including Tencent, FountainBridge C... |
| 02.03.2026 | XellSmart Receives Fourth Consecutive US FDA & China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy | SUZHOU, China, March 2, 2026 /PRNewswire/ -- In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with i... |
| 11.02.2026 | Chinese Edge AI Chip Leader Axera Lists on Hong Kong Stock Exchange | SHANGHAI, Feb. 11, 2026 /PRNewswire/ -- Axera, a portfolio company of Qiming Venture Partners and a leading Chinese edge AI chip company, successfully listed on the Hong Kong Stock Exchange on February 10th, 2026, Beijing time, becoming the... |
| 10.02.2026 | ShengShu Technology Completes Series A+ Funding of Over RMB 600 Million | has completed a Series A+ funding round of over RMB 600 million. The round was co-led by Zhongguancun Science City and LINK-X CAPITAL, with strategic investments from Wondershare, Visual China Group Co., Ltd., and TRS. Existing investors, i... |
| 10.02.2026 | SenseTime-backed robotics startup ACE Robotics closes angel round led by Ant Group | China-based artificial intelligence company SenseTime said today that embodied robotics startup ACE Robotics has completed an angel round, raising an undisclosed amount, led by Ant Group. Qiming Venture Partners, GVC, Hony Capital, Lenovo C... |
| 05.02.2026 | ShengShu Technology: Multimodal Video Model Developer Raises RMB 600M+ Series A+ | ShengShu Technology said it has completed a Series A+ funding round of more than RMB 600 million as it scales development and commercialization of its multimodal foundation models, including its Vidu video generation platform. The round was... |
| 05.02.2026 | ShengShu Technology Raises Over RMB 600M in Series A+ Funding | ShengShu Technology, a Beijing, China-based company providing multimodal generative AI models for various applications, raised over RMB 600M in Series A+ funding.
The round was co-led by Zhongguancun Science City and LINK-X CAPITAL, with pa... |
| 05.02.2026 | Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market | SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Insight Lifetech, a portfolio company of Qiming Venture Partners and a leading Chinese innovative medical device manfaucturer, successfully listed on the Shanghai Stock Exchange's STAR Market on Februa... |
| 05.02.2026 | ShengShu Technology Completes Series A+ Funding of Over RMB 600 Million | Leveraging Multimodal Foundation Models to Unlock AI Productivity in Digital and Physical Worlds
SINGAPORE, Feb. 5, 2026 /PRNewswire/ -- ShengShu Technology has completed a Series A+ funding round of over RMB 600 million. The round was co-l... |
| 02.02.2026 | Tenpoint Therapeutics Secures $235M, Prepares YUVEZZI Launch for Presbyopia | Tenpoint Therapeutics secured $235 million in new capital. This robust funding fuels the impending launch of YUVEZZI. YUVEZZI is an FDA-approved, first-of-its-kind dual-agent eye drop. It targets presbyopia, a widespread aging vision condit... |
| 01.02.2026 | China's AI Future: Hardware Dilemma Meets Funding Boom | China's AI sector navigates a complex duality. Top tech giants like Alibaba, Tencent, and ByteDance receive conditional approval to acquire 400,000 advanced Nvidia H200 AI accelerators. This move signals Beijing's pragmatic concession amid ... |
| 30.01.2026 | Baidu-backed new energy truck developer DeepWay raises $170m ahead of IPO | DeepWay Technology, the Baidu-backed Chinese new energy heavy-duty trucks developer which is in the process of a Hong Kong listing, has secured 1.177 billion yuan (almost $170 million) in a pre-IPO financing led by Puhua Capital.
DeepWay, w... |
| 30.01.2026 | Tenpoint Therapeutics: $235 Million Raised To Launch YUVEZZI Presbyopia Eye Drop | Tenpoint Therapeutics has secured $235 million in new funding to support the planned commercialization of its presbyopia treatment, YUVEZZI. The company said the capital combines an $85 million Series B preferred stock financing and a $150 ... |
| 29.01.2026 | As AI consolidates, what makes StepFun worth a RMB 5 billion raise? | StepFun’s Series B+ funding round, exceeding RMB 5 billion (USD 700 million), has drawn attention for its size. The investor mix and the speed at which the round closed are equally revealing. From launch to completion, the process took roug... |
| 29.01.2026 | Tenpoint Therapeutics: $235 Million Raised To Launch Dual Agent Presbyopia Eye Drop YUVEZZI | Tenpoint Therapeutics said it has secured $235 million in new capital, combining an $85 million Series B preferred stock financing with a $150 million senior secured term loan facility, as the company prepares to commercialize its newly app... |
| 26.01.2026 | Chinese AI Firm Stepfun Raises USD719 Mln for Model Development, AI Agent Rollout | (Yicai) Jan. 26 -- Stepfun, a Chinese artificial intelligence startup working closely with car giant Geely Automobile Holdings, has secured about CNY5 billion (USD719 million) to fast-track foundational model development, deploy AI agents, ... |
| 26.01.2026 | Shanghai AI unicorn StepFun raises over $718 million in B+ round | Shanghai-based large-model startup StepFun has completed a B+ financing round exceeding RMB 5 billion ($718 million), setting a new record for the largest single financing in China’s large-model sector over the past 12 months. The round saw... |
| 26.01.2026 | China’s investors double down on AI frontrunners as StepFun raises RMB 5 billion | StepFun has raised more than RMB 5 billion (USD 700 million) in a Series B+ funding round, according to PEdaily. The deal ranks among the largest private financings in China’s artificial intelligence sector so far this year.
The round drew ... |
| 12.01.2026 | Qiming-backed biotech Oricell raises $70m Series C1 round | - |
| 08.01.2026 | China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange | SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Qiming Venture Partners' portfolio company Z.ai (formerly known as Zhipu AI), a pioneer and leader inartificial general intelligence (AGI) in China, successfully listed on the Hong Kong Stock Exchange ... |
| 05.01.2026 | GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy | HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) h... |
| 02.01.2026 | Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange | SHANGHAI, Jan. 2, 2026 /PRNewswire/ -- Qiming Venture Partners' portfolio company Biren Technology, a leading domestic GPU developer, successfully listed on the Hong Kong Stock Exchange today, becoming the first company to go public in Hong... |
| 17.12.2025 | RedotPay raises $107M Series B led by Goodwater for stablecoin payments | - |
| 08.12.2025 | Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond | SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today announced the closing of a $10 million Seed finan... |
| 30.11.2025 | Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery | SHANGHAI, Nov. 30, 2025 /PRNewswire/ -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings in Wang Fuk Court in Tai Po, Hong Kong, causing severe casualties and drawing widespread public conce... |
| 24.11.2025 | GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics | Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology
Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs
SEOUL,... |
| 24.11.2025 | ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics | Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology
Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs
SEOUL,... |
| 17.11.2025 | Early Xiaomi backer Qiming targets $600m for ninth flagship USD fund: SEC filing | - |
| 14.11.2025 | Qiming goes smaller with new fund amid waning LP interest in China | - |
| 16.10.2025 | Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange | SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Yunji Technology, a global leader in the hospitality robotic-based AI agents market and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock Exchange on Octo... |
| 26.09.2025 | AusperBio Secures $63 Million for Targeted Hepatitis B Cure | AusperBio, a clinical-stage biotechnology firm, closed a $63 million Series B2 funding round. This substantial capital infusion will accelerate its mission. The company develops targeted oligonucleotide therapies. Its lead candidate, AHB-13... |
| 23.09.2025 | AusperBio: $63 Million Closed For Advancing Targeted Oligonucleotide Therapies | AusperBio, a biotechnology company focused on curing chronic hepatitis B, has announced it raised $63 million in Series B2 funding. This new investment adds to the strong financial backing the company has already received and reflects growi... |
| 22.09.2025 | AusperBio Raises $63M in Series B2 Funding | AusperBio, a San Francisco, CA-based privately held clinical-stage biotechnology company, raised $63M in Series B2 Funding.
The round was led by Qiming Venture Partners with participation from HanKang Capital, CDH Investments, YuanBio Ventu... |
| 08.09.2025 | Epigenic Therapeutics Closes $60M Series B Financing | Epigenic Therapeutics, a Shanghai, China-based clinical-stage drug development company, raised $60M in Series B funding.
The round was led by Lapam Capital, with participation from existing investors Qiming Venture Partners and OrbiMed, and... |
| 08.09.2025 | Epigenic Therapeutics Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic Medicines | SHANGHAI, Sept. 8, 2025 /PRNewswire/ -- Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series B round of financing led by Lapam Capital, wi... |
| 19.08.2025 | Early Xiaomi Backer Qiming Slashes Fund Goal to $600 Million | - |
| 11.08.2025 | Minghui Pharmaceutical Raises USD 131M in Pre-IPO Financing | Minghui Pharmaceutical, a Singapore-based clinical biopharmaceutical company, raised USD 131M Pre-IPO financing.
The round was led by new investors OrbiMed and co-led by Qiming Venture Partners with participation from existing investor TF C... |
| 10.08.2025 | OrbiMed, Qiming lead $131m pre-IPO financing for late-stage clinical biopharma Minghui | Global healthcare investment firm OrbiMed and Qiming Venture Partners have jointly led a pre-IPO financing of $131 million in Minghui Pharmaceutical, a Chinese late-stage clinical biopharmaceutical company, according to a statement.
Shangha... |
| 07.08.2025 | Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing to Advance Late-Stage Pipeline and Global Expansion | SHANGHAI, Aug. 7, 2025 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 million Pre-IPO financing led by new investors OrbiMed and co-led... |
| 28.07.2025 | XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury | SUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational clinical trial. This Phas... |
| 28.07.2025 | Chinese startup Z.ai launches powerful open source GLM-4.5 model family with PowerPoint creation | Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now
Another week in the summer of 2025 has begun, and in a continuation of the trend fr... |
| 28.07.2025 | China’s latest AI model claims to be even cheaper to use than DeepSeek | Startup Z.ai, formerly known as Zhipu, announced Monday that its new GLM-4.5 AI model would cost less than DeepSeek to use.
Like DeepSeek, the new model is also open source and can be downloaded for free.
At about half the size of DeepSeek’... |
| 10.07.2025 | Renasant Bio Raises $54.5M in Seed Funding | Renasant Bio, a Berkeley, CA-based developer of disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD), raised $54.5M in Seed funding.
The round was led by 5AM Ventures, alongside other life sciences investors... |
| 30.06.2025 | Qiming Venture Partners' Portfolio Company Unisound Successfully Lists on the Hong Kong Stock Exchange | SHANGHAI, June 30, 2025 /PRNewswire/ -- On June 30th, Beijing time, Unisound, a pioneer in the industrialization of AI technologies in China and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock... |
| 08.06.2025 | GenEditBio and Newborn Town: Pioneering Innovations in Hong Kong's Biotechnology and Entertainment Sectors | In the bustling heart of Hong Kong, two companies are making waves in their respective fields. GenEditBio, a biotechnology start-up, is pushing the boundaries of genetic medicine. Meanwhile, Newborn Town, a social entertainment giant, is re... |
| 06.06.2025 | GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World's First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal D... | HONG KONG, BEIJING and BOSTON, June 6, 2025 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology start-up company focusing on genome editing therapeutic solutions through the discovery of novel and pre... |
| 05.06.2025 | LP behind 'China's Silicon Valley' to back funds of Qiming, Monolith, others | Zhongguancun Science City (ZGC Science City), a local government investment firm in Beijing, will invest in funds managed by Qiming Venture Partners, Monolith Management, and Meituan’s DragonBall Capital, among two others, amid the growing ... |
| 09.05.2025 | The AIoT Revolution: Terminus Group and the Future of Smart Connectivity | The world is on the brink of a technological renaissance. By 2025, over 30 billion devices will be connected globally. This surge is not just a number; it’s a revolution. At the heart of this transformation lies AIoT—Artificial Intelligence... |
| 07.05.2025 | Budget brand no more? Pelliot readies Hong Kong IPO after profit surge | Pelliot first signaled its IPO ambitions in August 2023, when it filed for listing guidance with the Anhui arm of the China Securities Regulatory Commission. The goal was a debut on the Shenzhen Stock Exchange. But by April 2025, the compan... |
| 05.05.2025 | China’s PE-VC market braces for shakeup as tough times weed out trailing GPs | The ongoing reshuffle in Greater China’s private investment market is expected to intensify as significant macro challenges eliminate trailing managers with unwanted “zombie funds”. |
| 04.04.2025 | Streaming Giants and Storytelling Startups: A Tale of Triumph and Transition in India’s Digital Landscape | In the vast digital landscape of India, two narratives unfold: the roaring success of Amazon MX Player’s “Aashram” and the turbulent journey of Pratilipi, a digital storytelling platform. Both stories reflect the changing tides of entertain... |
| 04.04.2025 | Digital storytelling platform Pratilipi Raises USD 20 Mn in Series E round led by Jungle Ventures The Gurugram-based firm plans to utilise the funds to diversify into new storytelling formats such as ... | Digital storytelling platform Pratilipi has raised USD 20 million in its Series E round, led by Jungle Ventures.
The round includes USD 12 million in primary capital from two individual investors and USD 8 million via secondary share sales.... |
| 03.04.2025 | Jungle Ventures leads Series E funding in Pratilipi as Chinese VCs exit, valuation drops | Ranjeet Pratap Singh, co-founder and CEO, Pratilipi
Singapore-based venture capital firm Jungle Ventures has led a Series E funding round of $20 million (about Rs 171 crore) in digital storytelling platform Pratilipi.
The round includes $12... |
| 01.04.2025 | Aramco's Prosperity7 leads $73m financing in China's Spirit AI | Prosperity7 Ventures, a venture capital (VC) fund of Saudi oil giant Aramco, has led a Series Pre-A funding round of 528 million yuan ($72.8 million) in China’s Spirit AI amid a frenzy of early-stage financing in embodied intelligence.
Spir... |
| 12.03.2025 | DeepSeek AI cranks open the spigots on Chinese venture capital | DeepSeek’s artificial intelligence breakthrough has led to an “avalanche” of interest in Chinese tech firms over recent months.
It could mark a much-needed boost for the country’s investment landscape. VC investment into China-based compani... |
| 03.03.2025 | Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing | SHANGHAI, March 3, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This roun... |
| 25.02.2025 | Chip firm Biren plans Hong Kong IPO to raise $300 million funding, sources say | Chinese chip company Biren Technology is planning a Hong Kong IPO to raise around $300 million and is working with China International Capital Corporation, Bank of China International, and Ping An Securities on the potential stock sale, whi... |
| 19.02.2025 | China Digest: Nisa Leung departs from Qiming; Hony Capital to manage new Qianhai fund | Nisa Leung has officially stepped down from her position as a managing partner of Qiming Venture Partners, while China’s Hony Capital is the manager of a new fund. |
| 14.02.2025 | Deals in brief: Finmo’s Series A round hits oversubscription, Giftaway and HD raise fresh capital, latest China deals, and more | Finmo raises Series A funding to expand treasury management platform
Finmo, a treasury operating system provider, has raised USD 18.5 million in an oversubscribed Series A funding round, bringing its total funding to USD 27 million. The rou... |
| 13.02.2025 | New Blood in Innovation: Frank Yin Joins Washington Research Foundation | In the bustling world of innovation, fresh talent can spark a revolution. Frank Yin, Ph.D., is the latest addition to the Washington Research Foundation (WRF) as an investment associate. His mission? To unearth and nurture startup opportuni... |
| 13.02.2025 | Frank Yin joins Washington Research Foundation staff as investment associate | Washington Research Foundation
Yin's role will primarily focus on identifying and evaluating startup investment opportunities to advance Washington state innovations for public benefit
SEATTLE, Feb. 13, 2025 /PRNewswire-PRWeb/ -- Frank Yin,... |
| 20.01.2025 | Umoja Biopharma's $100 Million Leap: A New Era for In Vivo CAR T Cell Therapies | Umoja Biopharma is on the rise. The Seattle-based company has just secured $100 million in Series C financing. This is not just a number; it’s a statement. It signals a bold step forward in the world of biotechnology. The funding round was ... |
| 20.01.2025 | Umoja Biopharma Raises $100M in Series C Financing | Umoja Biopharma, a Seattle, WA-based clinical-stage company which specializes in vivo cell therapies, raised $100M Series C financing.
The round was led by Double Point Ventures and DCVC Bio, with participation from new and existing investo... |
| 14.01.2025 | Windward Bio: Charting New Waters in Immunology with $200 Million Series A Financing | In the vast ocean of biopharmaceutical innovation, Windward Bio has set sail with a robust $200 million Series A financing. This private, clinical-stage company aims to navigate the turbulent waters of immunological diseases, focusing on se... |
| 13.01.2025 | PE major EQT anchors Cornerstone Robotics's $70m funding | Swedish investment house EQT Group has anchored the $70-million Series C funding round in Hong Kong-headquartered surgical robotics firm Cornerstone Robotics, according to an announcement.
The round also saw the participation of a number of... |
| 13.01.2025 | Windward Bio launches with $200 million Series A financing round |
Windward Bio’s lead candidate, WIN378, which has been in-licensed from Kelun-Biotech and Harbour BioMed, is a potential best-in-class, long-acting monoclonal antibody targeting the ligand of thymic stromal lymphopoietin (TSLP) that has the... |
| 26.12.2024 | Chinese AI model maker Stepfun raises hundreds of millions in Series B funding
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to pr... | Chinese generative artificial intelligence model maker Stepfun has reportedly closed on a bumper funding round worth “several hundred million dollars” from a host of investors including state-owned private equity firms and local technology ... |
| 08.12.2024 | Soda Health: Health Tech Company Raises $50 Million (Series B) | Soda Health – a health tech company enhancing the use of benefit dollars to improve health outcomes and reduce inequities – announced a $50 million Series B financing. General Catalyst led the round with additional capital from former Human... |
| 04.12.2024 | Soda Health Raises $50M in Series B Funding | Soda Health, a Bentonville, AR-based health tech company enhancing the use of benefit dollars to improve health outcomes and reduce inequities, raised $50M in Series B funding.
The round was led by General Catalyst, with additional capital ... |
| 26.11.2024 | Shifting Sands: The Evolution of Investment Strategies in a Global Landscape | In the world of finance, change is the only constant. Recently, two stories emerged that highlight this truth. One is the leadership transition at Qiming Venture Partners, a major player in Chinese venture capital. The other is the growing ... |
| 25.11.2024 | Chinese VC firm Qiming Venture Partners prepares for leadership change | After months of speculation, leadership changes at Qiming Venture Partners have been confirmed.
Nisa Leung, a managing partner with 18 years at the firm, is stepping down, according to ChinaVenture. This move aligns with Qiming’s “ten-year ... |
| 16.11.2024 | Китайский стартап представил инструмент, генерирующий видео по картинкам лучше, чем Sora от OpenAI | Пекинская компания Shengshu Technology заявила, что ее инструмент Vidu для преобразования текста в видео на основе искусственного интеллекта теперь может генерировать видеоролики, объединяя несколько изображений, тем самым составляя конкуре... |
| 03.11.2024 | FII8 Day Three Ends with $70 Billion in Deals Announced | RIYADH, Saudi Arabia, Nov. 3, 2024 /PRNewswire/ -- The Future Investment Initiative (FII) Institute wrapped up Day 3 of its 8th annual gathering in Riyadh, with an "Investment Day" under the theme of "Infinite Horizons: Inves... |
| 26.10.2024 | WeRide's IPO: A New Era for Autonomous Driving | On October 25, 2024, WeRide took a giant leap into the future. The company, a leader in autonomous driving technology, officially listed on the Nasdaq under the ticker symbol "WRD." This moment marked a watershed in the tech world... |
| 26.10.2024 | Qiming Venture Partners Celebrates WeRide's IPO on Nasdaq | SHANGHAI, Oct. 26, 2024 /PRNewswire/ -- On October 25th, 2024, Beijing Time, WeRide, a world-leading autonomous driving company and Qiming Venture Partners' portfolio company, began trading on Nasdaq. This marks a historic milestone as both... |
| 18.10.2024 | LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing | Phase 1 trial of LM-299, an anti-PD-1/VEGF BsAb, initiated in China for advanced solid tumors following promising preclinical results demonstrating strong inhibition of tumor growth and well-tolerated safety profile
IND for LM-299 in the US... |
| 05.09.2024 | Deals in brief: Nvidia invests in Sakana AI and You.com, Zhipu AI secures new funding at RMB 20 billion valuation, six other China deals, and more | Nvidia deepens foothold in AI market with strategic backing of Sakana AI and You.com
Chip darling Nvidia continues to expand its foothold in the artificial intelligence space with major investments in AI companies.
On September 4, it was an... |
| 05.09.2024 | China aims to launch Mars sample-return mission around 2028
Taobao may soon allow users to pay through WeChat payment
Latest technology on show at three-day INCLUSION·Conference
WeChat support set to ... | China plans to carry out the Tianwen-3 mission through two launches around 2028, aiming to bring back samples from Mars, a Chinese space expert said on Thursday.
Liu Jizhong, chief designer of China's Mars sample-return mission, unveiled th... |
| 04.09.2024 | Deals in brief: Bateriku raises Series B funding, Antler invests in TailorTech, three China deals, and more | Bateriku raises USD 7.4 million in Series B round
Bateriku, a Malaysian provider of connected roadside assistance solutions, has raised USD 7.4 million in a Series B funding round. The investors include Kumpulan Wang Persaraan (KWAP), Gobi ... |
| 28.08.2024 | The Dance of Innovation: Chang’an and Huawei’s Strategic Partnership | In the fast-paced world of automotive technology, alliances can be as crucial as the vehicles themselves. Chang’an Automobile’s recent investment in Huawei’s subsidiary, Yinwang, exemplifies this dynamic. The deal, valued at RMB 11.5 billio... |
| 26.08.2024 | Deals in brief: Earth VC invests in Aalo Atomics, Sarana AI secures pre-seed funding, five China deals, and more | Earth Venture Capital invests in Aalo Atomics’ USD 27 million Series A round
Earth Venture Capital (Earth VC), a climate tech venture capital firm based in Vietnam, has invested in the USD 27 million Series A funding round of Aalo Atomics. ... |
| 13.08.2024 | RedDoorz Eyes IPO to Build Southeast Asia’s Largest Hospitality Firm | Southeast Asian online hotel management and booking platform RedDoorz has its sights set on IPO – but it has a lot of steps to clear first.
While the Indian IPO market is currently thriving, the global public markets are less favorable, Red... |
| 24.05.2024 | Revolutionizing Addiction Treatment: Boulder Care's $35M Funding Boost | Boulder Care, a trailblazer in telehealth addiction treatment, secures a game-changing $35 million Series C funding round to expand its reach and impact. With a focus on underserved communities, Boulder Care's innovative approach is set to ... |
| 24.05.2024 | China Digest: Qiming names managing partner; PhiGent raises $30m | Qiming Venture Partners has promoted Alex Zhou as a managing partner to spearhead investments in frontier technologies. Separately, autonomous driving solutions developer PhiGent Robotics has secured $30 million in a Series Pre-B funding ro... |
| 24.05.2024 | Boulder Care Secures $35M to Expand Telehealth Addiction Treatment for Underserved Communities | What You Should Know:
– Boulder Care, a leading provider of high-quality addiction treatment, announced today the successful closing of an oversubscribed $35M Series C funding round led by Advance Venture Partners (AVP), joined by Stripes a... |
| 23.05.2024 | Qiming Venture Partners Promotes Alex Zhou to Managing Partner | SHANGHAI, May 23, 2024 /PRNewswire/ -- Qiming Venture Partners, a global-leading venture capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner.
As a Qiming home-grown Managing Partner, Alex first joined the fir... |
| 30.08.2023 | Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development | SHANGHAI, Aug. 30, 2023 /PRNewswire/ -- Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy utilizing epigenome regulation to treat prevalent diseases, today announced that ... |
| 20.07.2023 | China's OpenAI Competitor Zhipu AI Receives Funding From Food Delivery Giant Meituan | Jace Dela Cruz, Tech Times 20 July 2023, 07:07 am
China's OpenAI challenger, Zhipu AI, has secured funding from the renowned food delivery giant Meituan, which currently has a market cap of approximately $100 billion. As reported in busines... |
| 19.07.2023 | China’s OpenAI challenger Zhipu AI gets Meituan funding | Zhipu AI, one of China’s most promising challengers to OpenAI, has received funding from the country’s food delivery giant Meituan, which has a market cap of around $100 billion at the time of writing.
An affiliate of Zhipu AI recently adde... |
| 15.06.2023 | Qiming Venture Partners fosters life science, medical and healthcare talent development First healthcare catalyst program starts recruiting in Hong Kong universities | SHANGHAI and HONG KONG, June 15, 2023 /PRNewswire/ -- Qiming Venture Partners ("Qiming") today launched its first "Catalyst: Qiming Healthcare Summer Program 2023" for universities in Hong Kong, fostering talent developm... |
| 06.06.2023 | LTZ Announces over $10 Million Pre-A+ Financing led by Qiming Venture Partners | - |
| 03.03.2023 | TandemAI Raises $35 Million in Series A Financing Led by Qiming Venture Partners | - |
| 31.01.2023 | China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq | SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- On January 25, Beijing time, QuantaSing Group Limited, a Qiming Venture Partners portfolio company and China's leading online adult interest learning service provider, successfully listed on Nasdaq. Q... |
| 31.01.2023 | China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq | SHANGHAI, Jan. 30, 2023 /PRNewswire/ -- On January 25, Beijing time, QuantaSing Group Limited, a Qiming Venture Partners portfolio company and China's leading online adult interest learning service provider, successfully listed on Nasdaq. Q... |
| 24.07.2022 | Qiming Venture Partners Announces Closing of US$3.2b Funds | - |
| 07.07.2022 | Chinese VC firm Qiming raises $3.2b for its latest two funds | InvestmentsNews
Aditya Hadi Pratama · 11 Jul 2022 · 2 min readChinese VC firm Qiming raises $3.2b for its latest two funds
Chinese VC firm Qiming Venture Partners announced that it has completed the final close of the US dollar-denominated ... |
